Unknown PHASE4 INTERVENTIONAL 1-arm NCT05099757

The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students

The Study on the Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students

Sponsor: Shanxi Medical University

Interventions 20 µg dose hepatitis B vaccine

Updated 5 times since 2021 Last updated: Dec 2, 2021 Started: Feb 20, 2022 Primary completion: Nov 25, 2022 Completion: Dec 15, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Hepatitis B Vaccine and is currently ongoing. Shanxi Medical University leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2024 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Jan 2022 — Jan 2024 [monthly]

Not Yet Recruiting PHASE4
Nov 2021 — Jan 2022 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanxi Medical University

Data source: Shanxi Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.